Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abbott, adenosine, adulthood, affirmative, alcohol, alia, Amazon, Appeal, ASC, ATP, begun, Beudeker, bottle, Bounty, brick, Bruce, CAGR, calendar, calorie, caption, capture, Carlo, ChromaPharma, citizen, coenzyme, constant, COSO, counter, Covance, creative, Dec, deceptive, declaratory, denied, denying, devoted, Diagonal, distributor, diversifying, Doctrine, DSM, earnout, ecommerce, elevated, enrichment, essential, Euromonitor, evolve, Farr, flagship, flat, Friedman, German, hair, ham, Hong, hurt, injunctive, insulin, inter, internet, inventor, Ka, Kevin, Kong, Kornberg, Lanham, lattice, Laureate, lawfully, leave, Li, libel, licensee, licensor, likewise, Macau, Matthew, Mayo, mediation, mislabeled, Monte, mortar, neurology, Nobel, noncash, offshore, older, opposed, outlined, outweigh, passed, PCAOB, Pharmavite, physical, pioneering, prejudice, Preliminary, prescribed, privilege, Professor, prominent, propriety, PTAB, put, ratified, ratifying, regional, repatriated, repealing, reply, resubstitution, revalued, Roger, rose, scrutiny, SDNY, Shing, signature, Singapore, social, sought, Southern, spent, staffing, standalone, Stanford, statute, Ste, stead, strike, substitute, substitution, surgery, Tanzi, taxation, therewith, thing, thought, threshold, triphosphate, TRU, true, trustworthy, unallocated, uncover, underpricing, unjust, unweighted, urge, vehicle, virtue, young, younger, youth
Removed:
acid, adulterating, advanced, allocation, biological, biologically, blocking, BluScience, burgeoning, capitalization, cardiovascular, characterization, cognitive, collateral, Combining, commitment, compound, conditioned, conversion, copy, customary, dark, database, degeneration, demonstration, designation, differentiation, digital, diligence, discount, Dongmyung, draft, earn, efficiently, elaborate, equated, establishment, ethnobotanical, ethnopharmacological, exist, extra, Fast, fatty, fee, founder, gap, generation, Geographical, glucose, herbal, highlight, HVAC, inclusion, investigate, investigational, involving, ISO, JMC, Korea, layer, literature, manager, milk, mitochondrial, neuropathy, NeutriSci, nominal, noted, oxidation, parent, peripheral, pertaining, pigment, pipeline, potency, potent, preferred, presence, principally, proportion, purpose, rating, receptive, recruitment, referencing, repayable, resistance, revise, routine, satisfied, scenario, secondary, secure, Segmentation, settle, Silliker, structure, subscription, Tiger, trace, treat, uniformity, utilized, variability, week, writing
Filing tables
Filing exhibits
- 10-K Annual report
- 3.1 Articles of Incorporation / Bylaws
- 10.66 Material Contracts
- 10.72 Material Contracts
- 21.1 Subsidiaries of the Registrant
- 23.1 Consents of Experts and Counsel
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated CDXC transcripts
CDXC similar filings
Filing view
External links
Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in the Registration Statement of ChromaDex Corporation and Subsidiaries on Form S-3 and as amended [File No. 333-222064, File No. 333-221245, File No. 333-218634 and File No. 333-203204] and on Form S-8 [File No. 333-221247, File No. 333-221246, File No. 333-196434, File No. 333-168029, File No. 333-154403 and File No. 333-154402] of our report dated March 15, 2018, with respect to our audits of the consolidated financial statements of ChromaDex Corporation and Subsidiaries as of December 30, 2017 and December 31, 2016 and for the years ended December 30, 2017, December 31, 2016 and January 2, 2016 and our report dated March 15, 2018 with respect to our audit of the effectiveness of internal control over financial reporting of ChromaDex Corporation and Subsidiaries as of December 30, 2017, which reports are included in this Annual Report on Form 10-K of ChromaDex Corporation and Subsidiaries for the year ended December 30, 2017.
/s/ Marcum LLP
Marcum LLP
New York, NY
March 15, 2018